Literature DB >> 13699231

Late complications of extraperiosteal lucite ball plombage.

M FEUCHTWANGER, J B BORMAN, I BRUDERMAN.   

Abstract

Keywords:  COLLAPSE THERAPY/complications

Mesh:

Substances:

Year:  1961        PMID: 13699231      PMCID: PMC1018621          DOI: 10.1136/thx.16.2.153

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

1.  Extraperiosteal plombage in the treatment of pulmonary tuberculosis.

Authors:  F H YOUNG
Journal:  Thorax       Date:  1958-06       Impact factor: 9.139

2.  The surgical management of late tuberculous space infections after plombage.

Authors:  A M MACARTHUR
Journal:  Thorax       Date:  1957-12       Impact factor: 9.139

3.  Extraperiosteal plombage in far advanced pulmonary tuberculosis; a review of fifty cases.

Authors:  H MILWIDSKY; H ROMANOFF
Journal:  Br J Tuberc Dis Chest       Date:  1956-10

4.  Extraperiosteal plombage thoracoplasty: operative technique and results with 161 cases with unilateral surgical problems.

Authors:  O ARMADA; W B O'BRIEN; W V VINDZBERG; N J WILSON
Journal:  J Thorac Surg       Date:  1956-12

5.  Surgical treatment of pulmonary tuberculosis.

Authors:  N J WILSON; O ARMADA; W B O'BRIEN; W V VINDZBERG
Journal:  Am J Surg       Date:  1955-03       Impact factor: 2.565

6.  Extraperiosteal Lucite ball plombage.

Authors:  F M WOODS; L BUENTE
Journal:  Am Rev Tuberc       Date:  1953-12

7.  Extraperiosteal temporary plombage in thoracoplasty: a preliminary report.

Authors:  F M WOODS; J H WALKER; I SCHMIDT
Journal:  Dis Chest       Date:  1950-11

8.  Thoracoplasty with plombage; a review of the early results in 125 cases.

Authors:  B G B LUCAS; W P CLELAND
Journal:  Thorax       Date:  1950-09       Impact factor: 9.139

  8 in total
  1 in total

1.  Treatment of late complications of plombage by simultaneous removal of plomb and decortication.

Authors:  A Moran; D E Stableforth; H R Matthews
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.